Teneligliptin Hydrobromide Teneligliptin HBr CAS 906093-29-6 CAS 906093-29-6 Maʻemaʻe > 99.5% (HPLC) DPP-4 ʻOihana Inhibitor

ʻO ka wehewehe pōkole:

Inoa Kemika: Teneligliptin Hydrobromide

Nā huaʻōlelo like: Teneligliptin HBr

CAS: 906093-29-6

Maʻemaʻe: >99.5% (na HPLC)

ʻIke: 99.5% ~ 102.0% (Anhydrous Substance)

ʻAno: Pahu keʻokeʻo a i ʻole keʻokeʻo

API DPP-4 inhibitor i ka mālama ʻana i ka maʻi maʻi type 2

E-Mail: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia ʻO Teneligliptin Hydrobromide
Nā huaʻōlelo like ʻO Teneligliptin HBr
Helu CAS 906093-29-6
Kūlana Kūʻai Ma ka waihona, hoʻonui ʻia a hiki i nā tona
ʻĀpana Molekala C22H32.5N6OSBr2.5
Kaumaha Molecular 628.86
Brand Kemika Ruifu

Nā kikoʻī:

Items Standards Rnā hopena
Cnā mea hana ʻino Pada keʻokeʻo a i ʻole keʻokeʻo Hoʻokō
Iʻike ʻike Na IR Hoʻokō
  Na HPLC Hoʻokō
Waiwai (KF) <6.00% 3.00%
Residue onIʻāʻā <0.50% 0.10%
HeavyMetals (e like me Pb) <20ppm Hoʻokō
Na mea pili ʻO kēlā me kēia haumia hoʻokahi: <0.10% 0.05%
  Huina haumia: <0.50% 0.15%
Maʻemaʻe / Kaʻina Hanana >99.5% (na HPLC) 99.85%
Hoʻāʻo 99.5%~102.0% (Anhydrous Meaʻai) 99.90%
Kūlana hoʻāʻo Kūlana ʻoihana
Ka hopena Ka HuahanaHoʻokōdiI-HaleKūlana.

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻOmole, ʻeke ʻeke Aluminum, 25kg / pahu pahu pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;E pale i ka malamalama a me ka wai

Pono:

1

FAQ:

Noi:

ʻO Teneligliptin Hydrobromide (CAS: 906093-29-6) he dipeptidyl peptidase-4 (DPP-4) inhibitor i hoʻohana ʻia e mālama i ka maʻi diabetes type 2.Hoʻopau ʻia ia ma o ka excretion, a he hapalua ke ola o 24.2 hola i loko o ke kino kanaka.ʻO Teneligliptin kahi mea pale DPP-4 i ʻae ʻia ma Iapana i ka makahiki 2012 no ka mālama ʻana i ka maʻi diabetes type II.Ua ʻike ʻia a hoʻomohala ʻia e Mitsubishi Tanabe Pharma ma lalo o ka inoa kālepa ʻo Tenelia®.E like me nā mea kūʻai aku DPP-4 i kūʻai ʻia, ua ʻae maikaʻi ʻia ka teneligliptin i nā haʻawina āpau a ua hana ka dosing QD i kahi hana hoʻopaʻapaʻa lōʻihi e kūʻē iā DPP-4 a me ka piʻi ʻana o nā pae GLP-1 ikaika, me nā haʻahaʻa haʻahaʻa loa o ka renal excretion.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou